Does CANNABIDIOL Cause Product use in unapproved indication? 1,585 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,585 reports of Product use in unapproved indication have been filed in association with CANNABIDIOL (Epidiolex). This represents 8.7% of all adverse event reports for CANNABIDIOL.
1,585
Reports of Product use in unapproved indication with CANNABIDIOL
8.7%
of all CANNABIDIOL reports
52
Deaths
233
Hospitalizations
How Dangerous Is Product use in unapproved indication From CANNABIDIOL?
Of the 1,585 reports, 52 (3.3%) resulted in death, 233 (14.7%) required hospitalization, and 3 (0.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANNABIDIOL. However, 1,585 reports have been filed with the FAERS database.
What Other Side Effects Does CANNABIDIOL Cause?
Seizure (4,980)
Hospitalisation (1,840)
Off label use (1,636)
Diarrhoea (1,356)
Death (1,115)
Somnolence (1,005)
Product dose omission issue (895)
Drug ineffective (859)
Fatigue (715)
Weight increased (663)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CANNABIDIOL Alternatives Have Lower Product use in unapproved indication Risk?
CANNABIDIOL vs CANNABIDIOL\HERBALS
CANNABIDIOL vs CANNABIS SATIVA FLOWERING TOP
CANNABIDIOL vs CANNABIS SATIVA SUBSP. INDICA TOP
CANNABIDIOL vs CANRENOATE
CANNABIDIOL vs CANRENOIC ACID